Joinn Laboratories (06127): Shareholders Gu Xiaolei and Gu Meifang have respectively reduced their holdings by 15.06 million shares and 7.4184 million shares. The reduction plan has been completed.

Joinn Laboratories (06127) announced that on March 17, 2026, shareholder Gu Xiaolei and its concerted action person Gu Meifang disclosed a plan to reduce their holdings. Within 3 months from the announcement of the reduction plan, Gu Xiaolei will reduce his holdings by no more than 5.02 million shares through the Shanghai Stock Exchange's centralized bidding method, and by no more than 10.04 million shares through block trading, totaling no more than 15.06 million shares, which is not more than 2.01% of the company's total share capital; Gu Meifang will reduce her holdings by no more than 2.47 million shares through the Shanghai Stock Exchange's centralized bidding method, and by no more than 4.94 million shares through block trading, totaling no more than 7.41 million shares, which is not more than 0.99% of the company's total share capital. Gu Xiaolei and its concerted action person Gu Meifang together will reduce no more than 3.00% of the company's total share capital. As of June 18, 2026, Gu Xiaolei and Gu Meifang have respectively reduced 15.06 million shares and 7.41 million shares, completing the implementation of the reduction plan.